SCHEMBL29664770

SCHEMBL29664770

OCC(F)(F)c1cccc2ncccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 3/20 0.40
HTT P42858 2/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 1/20 0.39
TRPV1 Q8NER1 2/20 0.39
NSD2 O96028 1/20 0.38
CYP3A4 P08684 2/20 0.37
NR3C1 P04150 1/20 0.37
CLK1 P49759 1/20 0.36
SSTR4 P31391 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23216915 1.00 MAPT (0.44) MAPTKDM4ELMNAHTTALDH1A1
SCHEMBL827601 0.80 MAPT (0.52) MAPTKDM4ELMNAHTTALDH1A1
SCHEMBL28781305 0.80 MEN1 (0.48) MAPTKDM4ELMNAHTTALDH1A1
SCHEMBL23232151 0.80 NSD2 (0.43) MAPTKDM4ELMNAHTTALDH1A1
Ammonia Solution, Strong SCHEMBL11973872 0.79 MAPT (0.50) MAPTKDM4ELMNAHTTALDH1A1
SCHEMBL28781316 0.77 MAPT (0.38) MAPTKDM4ELMNAHTTALDH1A1
Trifluoroacetic Acid SCHEMBL23215044 0.77 NSD2 (0.40) KDM4ELMNAHTTALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL29664501 0.77 NSD2 (0.40) KDM4ELMNAHTTALDH1A1SMN1; SMN2
SCHEMBL23215101 0.74 SSTR4 (0.41) MAPTKDM4ELMNAHTTALDH1A1
SCHEMBL23215045 0.74 ALDH1A1 (0.37) MAPTLMNAHTTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114729044-A Muscarinic acetylcholine M1Receptor antagonists 帕珀莱恩医疗公司 2022-07-08 CN disclosed